Syon Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Syon Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.59M	Buy	3,563 +355	+11%	+$166K	0.08%	185
2025 Q4	$1.45M	Buy	3,208 +369	+13%	+$159K	0.07%	199
2025 Q3	$1.11M	Sell	2,839 -481	-14%	-$201K	0.06%	233
2025 Q2	$1.48M	Buy	3,320 +13	+0.4%	+$5.99K	0.1%	147
2025 Q1	$1.6M	Buy	3,307 +947	+40%	+$441K	0.13%	116
2024 Q4	$950K	Sell	2,360 -157	-6%	-$72.8K	0.09%	165
2024 Q3	$1.17M	Sell	2,517 -24	-0.9%	-$11.5K	0.1%	147
2024 Q2	$1.19M	Buy	2,541 +71	+3%	+$30.8K	0.11%	135
2024 Q1	$1.03M	Sell	2,470 -2,082	-46%	-$880K	0.1%	150
2023 Q4	$1.85M	Buy	4,552 +2,387	+110%	+$882K	0.08%	160
2023 Q3	$753K	Buy	+2,165	New	+$757K	0.09%	134

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Syon Capital's VRTX Position: Q1 2026 in Review

Syon Capital increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q1 2026, buying an estimated $166K and bringing the position to 3,563 shares worth $1.59M. The position accounts for 0.08% of the portfolio, ranked #185.

Syon Capital first reported a position in VRTX in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.85M in Q4 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Syon Capital held 3,563 shares of Vertex Pharmaceuticals worth $1.59M as of Q1 2026.
Syon Capital bought 355 Vertex Pharmaceuticals shares in Q1 2026, an estimated $166K.
Vertex Pharmaceuticals made up 0.08% of Syon Capital's portfolio in Q1 2026, its #185 holding.
Syon Capital first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
Syon Capital's Vertex Pharmaceuticals position peaked at $1.85M in Q4 2023.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.